Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement
- PMID: 16144894
- DOI: 10.7326/0003-4819-143-5-200509060-00011
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement
Erratum in
- Ann Intern Med. 2005 Oct 4;143(7):547
Abstract
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility, along with the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, is included in the evidence synthesis available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The recommendation is also posted on the Web site of the National Guideline Clearinghouse (http://www.guideline.gov).
Comment in
-
Taking family history seriously.Ann Intern Med. 2005 Sep 6;143(5):388-9. doi: 10.7326/0003-4819-143-5-200509060-00015. Ann Intern Med. 2005. PMID: 16144898 No abstract available.
-
Genetic risk assessment and BRCA mutation testing.Ann Intern Med. 2006 Feb 21;144(4):303-4; discussion 304. doi: 10.7326/0003-4819-144-4-200602210-00017. Ann Intern Med. 2006. PMID: 16490919 No abstract available.
-
Review: only women with specific family histories should be referred for counseling or evaluation for BRCA breast and ovarian cancer susceptibility testing.ACP J Club. 2006 Mar-Apr;144(2):37. ACP J Club. 2006. PMID: 16539352 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical